Prompted by the previously reported preliminary data, we sought to clarify further the role of this pathway in NSCLC by assessing protein and gene expression of NF-κΒ2, RelB, Bcl3 and NIK in a bigger cohort. This evidence concerns the gene RELB and non-small cell lung carcinoma.